Accenture plc

(New York Stock Exchange)
Back to all articles
Somewhat Bullish +35

Accenture Jumped 28% in a Month and Now Trades Above Two Analysts’ $252 Targets

Analyst downgrade Analyst upgrade Company update AI-generated analysis

📈 Accenture shares jumped 28% in the past month after fiscal Q4 revenue of $18.7 billion beat the top of management's forecast.

📉 The stock rallied an additional 15.8% on Oct. 1, bringing the total gain to nearly 39% from its Sept. 30 close.

🎯 Fiscal 2027 guidance calls for 3% to 6% revenue and adjusted EPS growth in local currency.

💰 Acquisitions are estimated to supply 2% to 2.5 points of fiscal 2027 revenue growth, up from 1.5% last year.

🌱 Organic revenue growth is projected between 0.5% and 4% for fiscal 2027, down from 3.5% in fiscal 2026.

⚠️ CFO Angie Park warned that the bottom of the guidance range assumes client discretionary spending deterioration.

📊 Baird downgraded ACN to Neutral on Oct. 21 citing valuation concerns after the recent rally.

💵 Wells Fargo raised its price target to $252 but maintains an Equal Weight rating, questioning if Accenture is an AI winner.

🚀 UBS kept its Buy rating and raised its target to $300, which implies a 20x forward P/E multiple.

📉 The stock currently trades at a forward P/E of about 18x, well below its five-year average of 24x.

🔮 Analysts expect the December fiscal first-quarter report to be the next critical test for the stock's trajectory.

🏢 Management guided to 2% to 6% revenue growth for the upcoming quarter ending in December.

Bullish Signals
  • Accenture delivered a strong fiscal fourth-quarter revenue beat of $18.7 billion, exceeding the top of management's own forecast range.
  • The stock has rallied nearly 39% from its Sept. 30 close following the positive earnings surprise and subsequent market reaction.
  • UBS maintains a Buy rating with a raised price target of $300, suggesting confidence in the company's long-term prospects despite mixed analyst sentiment.
Risk Factors
  • Baird downgraded the stock to Neutral on Oct. 21, citing elevated valuation levels following the recent sharp rally.
  • Wells Fargo raised its target to $252 but maintains an Equal Weight rating, expressing skepticism that Accenture can prove itself as a true AI winner without organic revenue acceleration.
  • CFO Angie Park indicated that the bottom of the guidance range assumes a deterioration in clients' discretionary spending.
  • The current forward P/E of approximately 18x is significantly lower than the five-year average of 24x, reflecting market concerns about growth sustainability.
Full Analysis
Accenture (ACN) shares have surged approximately 28% over the past month, driven by a strong fiscal fourth-quarter revenue beat that exceeded the top of management's own forecast. The stock rallied an additional 15.8% on October 1 following the release of $18.7 billion in quarterly revenue, pushing the total gain to nearly 39% from late September levels. For the fiscal year ending August 2027, Accenture provided guidance for revenue and adjusted EPS growth between 3% and 6%. Management noted that acquisitions are expected to contribute roughly 2% to 2.5% of this total growth, leaving organic expansion projected at 0.5% to 4%, a significant deceleration from the 3.5% organic growth seen in fiscal 2026. Wall Street sentiment remains mixed regarding the stock's valuation relative to its earnings potential. While UBS maintains a Buy rating with a $300 price target, analysts at Baird and Wells Fargo have downgraded or maintained Neutral/Equal Weight ratings around $252, citing concerns that the current rally has priced in growth that may not materialize without organic acceleration. The company currently trades at a forward P/E of approximately 18x, significantly below its five-year historical average of 24x. Analysts suggest that future stock performance will likely track mid-single-digit earnings growth unless Accenture can demonstrate stronger organic revenue acceleration to justify higher valuation multiples.